previous compound ID: 1539 next compound
InChIKey: NZHGWWWHIYHZNX-CSKARUKUSA-N
SMILES: COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "J Liao" "D Rotin" "B Kus" "J Goepp" "JW Hanrahan" "R Robert" "DY Thomas" "SD Macknight" "E Matthes"

chemical graph of compound 1539





CID is 5282230
synonyms found at PubChem are:
tranilast, 53902-12-8, Rizaben, trans-Tranilast, Tranilastum, 70806-55-2, MK 341, N-(3,4-Dimethoxycinnamoyl)anthranilic acid, Tranilastum [INN-Latin], Tranilast [USAN:INN:JAN], Tranpro, UNII-HVF50SMY6E, Tranilast trans-, SB-252218, MK-341, Rizaben (TN), Tranilast (SB 252218), Tranilast (trans-), 3,4-DAA, n-(3',4'-dimethoxycinnamoyl) anthranilic acid, HVF50SMY6E, MLS000028468, C18H17NO5, CHEBI:77572, Anthranilic acid, N-(3,4-dimethoxycinnamoyl)-, NZHGWWWHIYHZNX-CSKARUKUSA-N, 2-((3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid, MFCD00864787, Tranilast sodium, (E)-2-(3-(3,4-dimethoxyphenyl)acrylamido)benzoic acid, NU-3450, NCGC00018185-05, SMR000058373, 2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid, 2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic Acid, T 0318, 53902-17-3, N-(3′,4′-Dimethoxycinnamoyl)anthranilic Acid, 2-[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enamido]benzoic acid, 2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino] benzoic acid, 2-{[(2e)-3-(3,4-Dimethoxyphenyl)prop-2-Enoyl]amino}benzoic Acid, tranilast hydrate, 2-({(2E)-3-[3,4-bis(methyloxy)phenyl]prop-2-enoyl}amino)benzoic acid, SR-01000003092, BENZOIC ACID, 2-((3-(3,4-DIMETHOXYPHENYL)-1-OXO-2-PROPENYL)AMINO)-, Molecule 20, N-(3&prime, AC1NQZP4, Opera_ID_1657, DSSTox_CID_3693, D00PVQ, D0E6OC, 2-[3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid, DSSTox_RID_77152, DSSTox_GSID_23693, Lopac0_001193, SCHEMBL29875, BSPBio_003561, ZINC797, MLS000759509, MLS001065902, MLS001077269, MLS001424045, MLS002207030, MLS006010043, Tranilast (JAN/USAN/INN), SPECTRUM1505333, CHEMBL415324, GTPL6326, Tranilast (JP17/USAN/INN), 2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]benzoic Acid, DTXSID7023693, BDBM21613, CHEBI:92320, AOB5086, MolPort-000-375-102, HMS2051F05, HMS2089L07, HMS2094I21, HMS2230F18, HMS3263P07, HMS3648A16, HMS3713J04, Pharmakon1600-01505333, BCP06359, BCP15888, HY-B0195, Tox21_110836, Tox21_501193, AC-940, CCG-39992, HSCI1_000076, NSC758970, SBB052710, AKOS002841076, Tranilast, >=98% (HPLC), powder, AN-6736, CS-2092, DB07615, KS-1193, LP01193, NC00171, NSC-758970, NCGC00018185-04, NCGC00018185-06, NCGC00018185-08, NCGC00018185-09, NCGC00018185-10, NCGC00018185-20, NCGC00021458-04, NCGC00021458-05, NCGC00021458-07, NCGC00261878-01, Rizaben;MK 341;Tranpro;SB 252218, BC204132, CPD000058373, I586, LS-37150, N 5', SAM001246737, SB252218, SC-12181, SBI-0051160.P003, AB0013774, AB2000109, CAS-53902-12-8, KB-226710, SB 252218, EU-0101193, KB-3357058, S1439, N-(3 ,4 -dimethoxycinnamoyl)anthranilic acid, D02027, AB00382987-18, AB00382987-19, AB00382987_21, 53902-12-8,104931-56-8(sodiumsalt), 902T173, Q-201849, SR-01000003092-2, SR-01000003092-4, SR-01000003092-9, BRD-K17849083-001-02-2, BRD-K17849083-001-03-0, BRD-K19533706-001-01-9, Rizaben, SB 252218, MK 341, Tranpro ,Tranilast, SR-01000003092-16, 2-[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid, (E)-2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid, 2-?[[3-?(3-?methoxy-?4-?propoxyphenyl)?-?1-?oxo-?2-?propen-?1-?yl]?amino]?-Benzoic acid, D27